The uric-acid derivatives were presumably formed as a result of initial cyclization of nitrosoaminouracils 1a and 1b
with glyoxylic acid to form intermediate I , which transformed during the reaction into intermediate I . Subsequent hydroxylation
1
2
and simultaneous decarboxylation of intermediate I gave uric-acid derivatives 2a and 2b.
2
The observed transformation of the nitrosoaminouracils represented a simple pathway to uric-acid derivatives under
mild conditions and in one step. The uric-acid derivatives were formed in high yields and could be easily isolated and
identified. Obviously, the observed transformation would be useful for studying purine metabolism in biological systems.
PMR spectra were recorded on a Bruker Avance-400 spectrometer. Mass spectra were obtained on a Shimadzu
GCMS-QP2010 Ultra at ionization potential 75 eV and 200°C.
Starting nitrosoaminouracils 1a and 1b and diaminouracils 3a and 3b were synthesized by the literature methods [2, 5].
Reaction of Nitrosopyrimidines 1a and 1b with Glyoxylic Acid. The appropriate 6-amino-5-nitrosopyrimidine-
2,4-dione 1 (1.5 mmol) and glyoxylic acid (6.0 mmol) in formic acid (5.0 mL) were heated at 50°C for 15–20 min. The
resulting precipitate of the corresponding uric-acid derivative 2 was filtered off and recrystallized from H O.
2
1
3-Methyl-1H-purino-2,6,8(3H,7H,9H)-trione (2a). Yield 67%, mp > 300ꢀÑ. Í NMR spectrum (400 MHz, DMSO-d ,
6
ꢁ, ppm, J/Hz): 3.24 (3Í, s, ÑÍ ), 10.69 (1Í, s, NH), 10.96 (1Í, s, NH), 11.78 (1Í, s, NH). Mass spectrum (EI, 70 eV), m/z
3
+
(I ,%): 182 ([M ], 67), 139 (67), 111 (16), 83 (34), 68 (100). C H N O .
rel
6 6 4 3
1
1,3-Dimethyl-1H-purino-2,6,8(3H,7H,9H)-trione (2b). Yield 70%, mp > 300ꢀÑ. Í NMR spectrum (400 MHz,
DMSO-d , ꢁ, ppm, J/Hz): 3.11 (3H, s, ÑÍ ), 3.21 (3H, s, ÑÍ ), 10.65 (1Í, s, NH), 11.79 (1H, br.s, NH). Mass spectrum
6
3
3
+
(EI, 70 eV), m/z (I ,%): 196 ([Ì ], 95), 139 (43), 111 (15), 83 (36), 68 (100). C H N O . The PMR spectrum of 2b agreed
rel
7 8 4 3
with that in the literature [6].
Methyl (6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)carbamate (4). Compound 3b
(60.0 mg, 0.35 mmol) and methyl chloroformate (0.5 mL, 5.3 mmol) in MeCN (2.0 mL) were heated at 80°C for 4 h.
1
The resulting precipitate of 4 was filtered off. Yield 85%, mp 214–215ꢀÑ. Í NMR spectrum (400 MHz, DMSO-d , ꢁ, ppm,
6
J/Hz): 3.09 (3H, s, ÑÍ ), 3.15 (3H, s, ÑÍ ), 3.61 (3H, s, ÑÍ ), 6.56 (2H, s, NH ), 7.48 (1H, s, NH). Mass spectrum (EI, 70 eV),
3
3
3
2
+
m/z (I ,%): 228 ([M ], 24), 196 (100), 168 (15), 142 (13), 83 (70). C H N O .
rel
8 12 4 4
REFERENCES
1.
D. T. Hurst, An Introduction to the Chemistry and Biochemistry of Pyrimidines, Purines and Pteridines,
John Wiley & Sons, Chichester, New York, Brisbane, and Toronto, 1980, 266 pp.
F. F. Blicke and H. C. Godt, J. Am. Chem. Soc., 76, 2798 (1954).
G. Zvilichovsky, H. Garbi, and E. Nemes, J. Heterocycl. Chem., 19 (1), 205 (1982).
A. Taniguchi and N. Kamatani, Jpn. J. Clin. Med., 12 (66), 2378 (2008).
2.
3.
4.
5.
6.
H. B. Cottam, H. Shih, L. R. Tehrani, D. B. Wasson, and D. A. Carson, J. Med. Chem., 39, 2 (1996).
V. N. Bobkov, T. V. Zvolinskaya, and I. I. Kuzmenko, Chem. Heterocycl. Compd., 27 (5), 560 (1991).
604